Tess Burleson - 07 Jun 2022 Form 4 Insider Report for Salarius Pharmaceuticals, Inc. (SLRX)

Role
Director
Signature
/s/ David J. Arthur, Attorney-in-Fact
Issuer symbol
SLRX
Transactions as of
07 Jun 2022
Transactions value $
$4,986
Form type
4
Filing time
08 Jun 2022, 15:14:30 UTC
Previous filing
21 Jan 2022
Next filing
05 Jan 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLRX Common Stock Purchase $4.99K +27.7K +636.78% $0.18 32.1K 07 Jun 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.